Mouse IgG1 Isotype Control (Clone HKSP) – Purified in vivo GOLD™ Functional Grade
Pricing & Details
Antibody DetailsProduct DetailsHost Species Mouse Product Concentration ≥ 5.0 mg/ml Endotoxin Level ≤ 1.0 EU/mg as determined by the LAL method Purity ≥95% monomer by analytical SEC ⋅ >95% by SDS Page Formulation This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Product Preparation Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Storage and Handling Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day 2-8°C Working Concentration This Mouse IgG isotype control antibody should be used at the same concentration as the primary antibody. RRIDAB_2737545 Applications and Recommended Usage? Quality Tested by Leinco FC This isotype control antibody should be used at the same concentration as the primary antibody. Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionSpecificity This Mouse IgG1 isotype control antibody (Anti-BTV) has been tested against selected species' cells and tissues to assure minimal cross reactivity. Research Area Cell Biology References & Citations1.) Crack, Peter J. et al. (2016) eNeuro 10.1523/ENEURO.0128-15.2016 Article Link 2.) Shin, Haina et al. (2018) J Virol. 92(7): e00038-18. PubMed 3.) Karki et al. (2021) Cell. 184:149–168 Journal Link 4.) Ortiz et al. (2019) Cancer Cell. 35:33–45 Journal Link 5.) Smyth et al. (2020) Cancer Immunol Res 8:1-12 Journal Link 6.) Swaminathan, S. et al. (2020) Nat Commun 11: 2860 Journal Link 7.) Karki, R. et al. (2020) Cell 184(1):149–168.e17 Journal Link Technical Protocols |
Related Products
Prod No. | Description |
---|---|
C1221 |
|
C1222 |
Formats Available
Prod No. | Description |
---|---|
I-128 |
|
I-907 |
|
I-536 |
|
I-104 |
|
I-133 |
|
I-103 |
|
M1411 |